![]() |
Volumn 174, Issue 7, 2001, Pages 338-341
|
Hepatitis A epidemiology in Australia: National seroprevalence and notifications
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS A ANTIBODY;
HEPATITIS A VACCINE;
ADOLESCENT;
ADULT;
AGE;
AGED;
ARTICLE;
AUSTRALIA;
CHILD;
COST BENEFIT ANALYSIS;
DISEASE PREDISPOSITION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GEOGRAPHIC DISTRIBUTION;
HEALTH SURVEY;
HEPATITIS A;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
INFECTION CONTROL;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
POPULATION RESEARCH;
SERODIAGNOSIS;
SEROPREVALENCE;
SERUM;
SEX DIFFERENCE;
VACCINATION;
|
EID: 0035794777
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2001.tb143309.x Document Type: Article |
Times cited : (19)
|
References (33)
|